ResMed Inc.
RMD | NYSE
$224.56
+$0.95 (+0.42%)
Sep 22, 2026, 2:37 PM ET · Market open
Market Data
Market Cap $32.44B
Enterprise Value $31.79B
Beta 0.77
Average Volume 1.53M
Shares Outstanding (Diluted) 144.98M
Shares Change YoY -1.4%
Institutional Ownership 66.71%
Exchange NYSE
ISIN US7611521078
Price Performance
Price Change 1M -3.2%
Price Change 3M 16.9%
Price Change 6M -1.2%
Price Change YTD -8.7%
Price Change 1Y -18.5%
Price Change 3Y 63.7%
Price Change 5Y -20.0%
1M CAGR (ann.) 5.8%
1Y CAGR (ann.) -17.3%
5Y CAGR (ann.) -4.1%
All-Time CAGR 13.4%
Valuation
PE Ratio 21.50
Forward PE 18.54
PEG Ratio 2.30
Forward PEG 2.14
PS Ratio 5.74
Forward PS 5.60
PB Ratio 4.93
P/FCF Ratio 11.23
P/Adj. FCF Ratio 11.98
P/OCF Ratio 10.25
EV/Sales 5.62
EV/EBIT 16.32
EV/EBITDA 14.81
EV/FCF 11.00
Earnings Yield 4.7%
FCF Yield 8.9%
Adj. FCF Yield 8.3%
Financial Health
Net Cash $780.73M
Total Debt $825.92M
Cash & Short-Term Investments $1.47B
Total Assets $8.97B
Current Ratio 3.10
Quick Ratio 2.42
Debt / Equity Ratio 0.13
Debt / EBITDA 0.38
Debt / FCF 0.29
OCF / Debt 3.82
Interest Coverage 65.20
Altman Z-Score 11.05
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 61.2%
Operating Profit Margin 33.5%
EBITDA Margin 38.0%
Net Profit Margin 26.9%
FCF Margin 51.1%
Adj. FCF Margin 47.9%
SBC / Revenue 3.2%
SBC Impact (per share) -6.3%
Returns
Return on Assets 17.0%
Return on Equity 23.9%
Return on Invested Capital 19.1%
Return on Capital Employed 25.0%
Return on Tangible Assets 27.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 10.2%
Revenue CAGR 5Y 12.1%
Revenue CAGR 10Y 11.9%
EPS CAGR 3Y 19.5%
EPS CAGR 5Y 26.3%
EPS CAGR 10Y 15.5%
FCF CAGR 3Y 72.9%
FCF CAGR 5Y 36.0%
FCF CAGR 10Y 19.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 35
EPS Growth Next 3Y 11.8%
Revenue Growth Next 3Y 5.2%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) $2.72
EPS Growth Est (next Q) 6.7%
Revenue Est (next Q) $1.39B
Revenue Growth Est (next Q) 4.2%
Fair Value Estimates
Graham Number $103.20
Graham Upside -53.9%
Lynch Fair Value $260
Lynch Upside 16.3%
Price Target $242.70
Price Target Upside 8.5%
Cash Flow
Operating Cash Flow $3.16B
Free Cash Flow $2.89B
Adj. Free Cash Flow $2.71B
FCF Per Share $19.97
OCF Per Share $21.82
OCF/S Ratio 55.8%
Income Statement
Revenue $5.65B
Gross Profit $3.46B
Operating Income $1.89B
EBITDA $2.15B
Net Income $1.52B
EPS (Diluted) $10.40
Revenue / Employee $497.22K
Profit / Employee $133.97K
Employees 11,370
Dividends
Annual Dividend $2.46
Dividend Yield 1.10%
Payout Ratio 23.6%
FCF Payout Ratio 21.2%
Adj. FCF Payout Ratio 22.6%
Dividend Growth (YoY) 12.3%
Pay Frequency Quarterly
Ex-Dividend Date Aug 19, 2026
Add to Watchlist
Select watchlists to add or remove RMD